Johnson and Johnson recalls Tylenol created at shuttered facility

A Tylenol recall has been declared for merchandise produced at a McNeil Consumer Healthcare plant by its parent company, Johnson and Johnson. The fifth Tylenol recall in the past year was announced with a congressional investigation in progress of McNeil Consumer Healthcare’s level of quality manage procedures. The latest Tylenol recall was initiated due to consumer complaints of a musty scent coming from the containers.

The recall of 8-hour Tylenol

The latest Tylenol recall had been announced Monday. Johnson and Johnson’s McNeil Consumer Healthcare division voluntarily removed about 128,000 bottles of 50-count Tylenol 8-Hour Caplets. The New York Times accounts that McNeil initiated the Tylenol 8-Hour recall after consumers complained of a “musty or moldy odor” in goods sold within the U.S. and Puerto Rico. The Tylenol recalled had been made at the company’s troubled Fort Washington, Pennsylvania, plant before the facility was closed in March. The moldy smell probably came from the very same thing that caused the recall in January, June and July with merchandise that came from the McNeil plant in Puerto Rico and that had been a chemical that got into the Tylenol when the business was treating wooden transport pallets.

Just keep seeing these Tylenol recalls

Because Johnson and Johnson have had several recalls this year, Congress has decided to look into it. Due to nausea, stomach pain, vomiting and diarrhea, five lots of 100-count Tylenol Arthritis Pain were recalled, accounts Cable News Network, just last Nov. Then in Dec, there had been another recall. This recalled of the lots. The recall was then expanded even further to non-prescription drugs causing scent and nausea with things such as Tylenol and Motrin. Then in May, 50 children’s medicines were added to the recall. There were safety concerns and quality control issues that brought on this.

Not performing a good job with command

In April, Johnson and Johnson closed the McNeil plant. Reuters reports the business has since been revamping the plant’s quality manage plans to address violations uncovered in an investigation by inspectors from the U.S. FDA. According to the FDA, the facility had contaminated drug ingredients. There was also dust and grime everywhere. Drugs manufactured at the Fort Washington plant contributed sales of about $650 million a year to Johnson and Johnson’s bottom line. Based on Bloomberg, the recalls and facility closings will cost the company a lot. In fact, $600 billion could be lost this year because of it.

Citations

New York Times

prescriptions.blogs.nytimes.com/2010/10/18/more-trouble-with-tylenol/?partner=rss and emc=rss

CNN

cnn.com/2010/HEALTH/10/19/tylenol.recall/index.html?npt=NP1

Reuters

reuters.com/article/idUSTRE69I2W320101019